The longevity biotech sector has grown significantly over the past decade, attracting billions in venture capital and corporate investment. This database tracks the companies and research organizations actively developing age reversal interventions, from early-stage laboratory research to clinical-stage drug development.

Altos Labs

Cellular rejuvenation and reprogramming using partial reprogramming factors

Private biotech

Calico

Aging biology and longevity research

Alphabet-backed research company

Retro Biosciences

Cellular drivers of aging and healthy lifespan extension

Private biotech

Unity Biotechnology

Senolytic therapies to clear senescent cells

Public biotech

BioAge Labs

AI-driven identification of longevity drug targets

Private biotech
Research publication: Evidence levels are noted per entry. This content is for educational purposes and does not constitute medical advice. Data reflects current research status and is updated as the field evolves.